WHAT CYBERKNIFE TREATS


Prostate Cancer | Brain Cancer | Lung Cancer | Liver Cancer | Pancreas Cancer | Spine Cancer

At FROS Cyberknife Center our physicians have the experience to treat your cancer with the Cyberknife. The Cyberknife treats cancers in the prostate, lung, brain, liver, spine, pancreas, kidney and other areas. The Cyberknife is unique in its capability to treat recurrent cancer patients who have already received traditional radiation. The treatment – which delivers high doses of radiation to tumors with extreme accuracy – offers new hope to patients who have inoperable or surgically complex tumors, or who may be looking for a non-surgical option. To date, more than 100,000 patients have been treated with the Cyberknife.

Prostate Cancer

The CyberKnife® Robotic Radiosurgery System was cleared by the U.S. Food and Drug Administration in 2001 to treat tumors anywhere in the body, including the prostate. The challenge that doctors face in treating prostate tumors with radiation therapy is that the prostate moves unpredictably as air passes through the rectum and as the bladder empties and fills. Minimizing any large movements of the prostate can help reduce unnecessary irradiation of surrounding healthy tissue.

The CyberKnife® Robotic Radiosurgery System is able to overcome this challenge by continuously identifying the exact location of the prostate tumor throughout the course of the treatment. During CyberKnife treatment, a patient can lie still and breathe normally while the doctor zeroes in on a moving target – the prostate – and irradiates it without harming surrounding areas. As a result, the procedure is more comfortable for patients, radiation is delivered more accurately and treatments are completed in five days.

Cyberknife Information Guide:

Download CyberKnife Prostate Cancer Treatment Guide

Cyberknife Prostate Video:

 

 

Warrens Cancer Chronicles

 

 


Brain Cancer

The CyberKnife System offers patients a non-invasive alternative to brain cancer surgery, and can be used for brain tumors that are considered inoperable because of their location in the head, patients who cannot undergo brain cancer surgery due to their poor medical condition, or those who refuse surgery. The CyberKnife System also can treat benign, or non-cancerous, tumors and other conditions, such as trigeminal neuralgia and arterial venous malformations (AVMs).

CyberKnife brain cancer treatments are performed on an outpatient basis over a period of one to five days, requiring no overnight hospital stays. Most patients experience minimal to no side effects with a quick recovery time.

The CyberKnife Robotic Radiosurgery System improves on other radiosurgery techniques by eliminating the need for stereotactic frames. As a result, the CyberKnife System enables doctors to achieve a high level of accuracy in a non-invasive manner and allows patients to be treated on an outpatient basis. The CyberKnife System can pinpoint a tumor’s exact location in real time using X-ray images taken during the brain cancer treatment that reference the unique bony structures of a patient’s head.

Cyberknife Brain Video:

 

 


Lung Cancer

The CyberKnife System offers patients who cannot undergo lung cancer surgery due to their poor medical condition, or who refuse surgery, a minimally invasive alternative treatment for lung cancer. CyberKnife lung cancer treatments are typically performed on an outpatient basis in one to five days. Most patients experience minimal to no side effects with a quick recovery time.

The challenge that doctors face with tumors in the lung is that those tumors move as the patient breathes. Radiosurgery devices, such as the CyberKnife® Robotic Radiosurgery System, offer patients a new option for the treatment of lung cancer. Unlike traditional radiation therapy, the CyberKnife System precisely identifies the tumor location as the patient breathes normally during treatment and can be used, in some cases, to treat lung tumors non-invasively.

Cyberknife Lung Video:

 

 


Liver Cancer

Treating liver cancer with radiation therapy is a challenge because liver tumors move with respiration. In addition, the tissue in the surrounding liver is very sensitive and can be damaged easily. The CyberKnife Radiosurgery System is able to deliver very high doses of radiation to both primary and metastatic liver tumors with extreme accuracy. Working in conjunction with the CyberKnife System is the Synchrony® Respiratory Tracking System, which enables the radiation beam to track tumor movement in real time and allows patients to breathe normally during their treatment sessions. With the CyberKnife System, doctors can zero in on a moving target – the liver tumor – and irradiate it without harming the healthy surrounding tissue. As a result, the CyberKnife treatment is more comfortable for patients, radiation is delivered more accurately and treatments can be completed in one to five sessions.

Cyberknife Liver Cancer Video:

 

 


Pancreas Cancer

The CyberKnife System has been used to treat pancreatic cancer in patients who are poor surgical candidates, refuse surgery, or for whom surgery or other treatments have failed.

Treating tumors in and near the pancreas with radiation is challenging because those tumors move as you breathe, making it difficult to target them accurately with radiation. As a result, the tumor may not receive enough radiation and healthy tissue near the tumor may be damaged. With other kinds of radiation therapy – often referred to as conventional, external-beam, or intensity-modulated radiotherapy – the total radiation dose is divided up into smaller doses delivered over 25 to 40 sessions in order to minimize damage to surrounding healthy tissue. CyberKnife radiosurgery is intended to destroy, or ablate, the tumor tissue with high doses delivered in one to five sessions. To do that safely requires a highly accurate system that detects the movement of the tumor throughout treatment sessions and delivers the radiation with pinpoint precision.

Working in conjunction with the CyberKnife System is the Synchrony® Respiratory Tracking System, which enables the radiation beam to track tumor movement in real time and allows patients to breathe normally during their treatment sessions. With the CyberKnife System, doctors can zero in on a moving target – the pancreatic tumor – and irradiate it without harming the healthy surrounding tissue. As a result, the CyberKnife treatment is more comfortable for patients, radiation is delivered more accurately and treatments can be completed in one to five sessions.

Cyberknife Pancreas Video:

 

 


Spine Cancer

The CyberKnife System offers patients a new option for spine cancer treatment. Unlike conventional radiation therapy, during which low doses of radiation are delivered over weeks and months, the CyberKnife System can treat a tumor in one to five days by delivering a high dose of radiation with extreme accuracy.

Spine tumors present a treatment challenge because they move as the patient breathes. Conventional radiation therapy cannot account for this movement, so surrounding healthy tissue is damaged by the radiation. The CyberKnife System is able to achieve a high level of accuracy completely non-invasively – without the use of body frames or implanted fiducial markers. It can pinpoint a tumor’s exact location in real time throughout treatment.

The CyberKnife System allows the patient to breathe normally while on the treatment table, enabling the doctor to zero in on the moving tumor and focus radiation on the tumor. Using this method, the CyberKnife System is able to deliver a high dose of radiation to the tumor while avoiding damage to the surrounding sensitive spinal cord tissue and other critical structures. As a result, radiation is delivered more accurately and treatments can be performed in a shorter period of time.

Cyberknife Spine Video:

At FROS Radiation Oncology Cyberknife Center, our team is committed to bringing leading-edge technology with highly compassionate care to our patients.

Please call us at 1-888-880-6646 today to find the right treatment for you.

IN THE NEWS

August 28, 2013

June 1, 2013

FROS attending physicians, Alan Katz and Josephine Kang, to give an oral presentation at this year's ASTRO meeting on long term outcomes after stereotactic body radiation therapy (SBRT) for prostate cancer.

VIDEOS

The Redefining Radiosurgery Video gives definitive clinical, hospital and patient benefits as compared to other radiation therapy and systems.

Contribute!

LOCATIONS

Flushing: 40-22 Main St, 4th Fl,
Flushing, NY 11354
Brooklyn: 1737 Bath Ave
Brooklyn, NY 11214
Manhattan: 47 Essex St.
New York, NY 10002

STAY CONNECTED

Stay in touch with FROS Radiation Oncology & Cyberknife Centers. Join us on Facebook, Twitter and LinkedIn for latest news and info.